Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,204
Closed -$1.4M 2090
2024
Q2
$1.4M Sell
20,204
-4,044
-17% -$295K 0.01% 1060
2024
Q1
$1.94M Buy
+24,248
New +$2.16M 0.01% 1004
2023
Q1
Sell
-4,582
Closed -$406K 2167
2022
Q4
$406K Buy
4,582
+1,684
+58% +$140K ﹤0.01% 1651
2022
Q3
$232K Sell
2,898
-25,056
-90% -$2.36M ﹤0.01% 2258
2022
Q2
$2.68M Sell
27,954
-16,045
-36% -$1.93M 0.03% 662
2022
Q1
$6.54M Sell
43,999
-29,937
-40% -$4.18M 0.06% 369
2021
Q4
$10.5M Buy
+73,936
New +$10.5M 0.1% 276
2021
Q3
Sell
-10,100
Closed -$1.39M 2197
2021
Q2
$1.39M Sell
10,100
-22,113
-69% -$3.03M 0.01% 837
2021
Q1
$4.21M Buy
+32,213
New +$3.88M 0.05% 471
2020
Q4
Sell
-8,800
Closed -$692K 1613
2020
Q3
$692K Sell
8,800
-12,272
-58% -$1M 0.01% 813
2020
Q2
$1.52M Sell
21,072
-328
-2% -$22.8K 0.04% 487
2020
Q1
$1.23M Buy
21,400
+16,128
+306% +$1.49M 0.08% 306
2019
Q4
$589K Buy
5,272
+2,772
+111% +$295K 0.01% 684
2019
Q3
$240K Buy
+2,500
New +$235K 0.01% 853
2018
Q3
Sell
-3,700
Closed -$271K 827
2018
Q2
$271K Sell
3,700
-3,862
-51% -$263K 0.01% 650
2018
Q1
$479K Buy
+7,562
New +$451K 0.04% 489
2016
Q3
Sell
-17,770
Closed -$848K 435
2016
Q2
$848K Buy
+17,770
New +$752K 0.19% 151

Other funds holding CNMD

Steve Schonfeld's CNMD Position: Q3 2024 in Review

Steve Schonfeld sold out of CONMED (CNMD) in Q3 2024, closing a stake of 20,204 shares — an estimated $1.4M sold.

Steve Schonfeld first reported a position in CNMD in Q2 2016 and held it in 17 quarters. The position peaked at $10.5M in Q4 2021. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Steve Schonfeld reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
  • Steve Schonfeld sold 20,204 CONMED shares in Q3 2024, an estimated $1.4M.
  • Steve Schonfeld first reported a position in CONMED in Q2 2016 and held it in 17 quarters.
  • Steve Schonfeld's CONMED position peaked at $10.5M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.